Biotech Investors & VC Firms in North America
1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.
Daft Capital
Palo AltoPre-Seed–Series B$500K – $2M
1 person
JStar Capital Investments
AustinSeed–Series C
13 people
AbCellera
VancouverSeries B–Late Stage
21 people
Morgenthaler
Portola ValleyPre-Seed–Series C
9 people
Endeavor8
San Francisco
11 people
Lemhi Ventures
JordanSeed–Series A$500K – $5M
5 people
Altium Capital
New YorkGrowth
7 people
BioStar Capital
CharlevoixSeed–Series A$250K – $3M
10 people
FCA Health Innovations QP
Nashville
10 people
FTW Ventures
San FranciscoPre-Seed–Series A$100K – $500K
4 people
The Vertical Group
Berkeley HeightsSeed–Series B$250K – $5M
4 people
Xcellerant Ventures
ScottsdaleSeed–Series A
13 people
Asia2G Capital
Silicon ValleySeed–Series A
6 people
IPD Capital
AventuraSeed–Series B
8 people
Valkyrie Ventures Management, Llc
Park CityPre-Seed–Growth
2 people
New Jersey Economic Development Authority
TrentonPre-Seed–Growth
13 people
3CC | Third Culture Capital
BostonPre-Seed–Series A$250K – $1M
6 people
Character
MilwaukeePre-Seed–Series A$2M
3 people
Curie.Bio
CambridgeSeed–Series A$5M – $15M
9 people
Verge Fund
AlbuquerquePre-Seed–Series A$100K – $500K
9 people
Helios Capital
MiamiPre-Seed–Series A$25K – $1M
2 people
Venture Capital Investment Management
San FranciscoSeed–Series A
7 people
1955 Capital
San FranciscoPre-Seed–Series A$5M – $10M
6 people
Bison Ventures
SeattleSeed–Series A
6 people
Related lists
Investors & VC Firms in North America (13518)Investors & VC Firms in United States (12555)Investors & VC Firms in Europe (5846)Investors & VC Firms in Global (4720)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4215)Healthtech Investors & VC Firms (4185)Enterprise Software Investors & VC Firms (4097)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.






























































































